Oral mucosal immunization using glucomannosylated bilosomes

Journal of Biomedical Nanotechnology

Volumn 10, Issue 6, 2014, Pages 932-947

  Jain, Sanyog ^a   Indulkar, Anura ^a   Harde, Harshad ^a   Agrawal, Ashish K ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Bilosomes; Glucomannosylation; Mucosal immunization; Oral immunization; Vaccine

Indexed keywords

ANTIGENS; BODY FLUIDS; IMMUNE SYSTEM; VACCINES;

BILOSOMES; CONFORMATIONAL STABILITIES; ENTRAPMENT EFFICIENCY; FREEZE-DRIED FORMULATIONS; GLUCOMANNOSYLATION; MUCOSAL IMMUNE RESPONSE; MUCOSAL IMMUNIZATION; RAW 264.7 MACROPHAGES;

IMMUNIZATION;

BILE SALT; BOVINE SERUM ALBUMIN; DRUG VEHICLE; GLUCOMANNOSYLATED BILOSOME; IMMUNOGLOBULIN G; MANNAN; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BILOSOMAL DELIVERY; CELL ADHESION; CELLULAR IMMUNITY; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG STABILITY; DRUG UPTAKE; ELECTROPHORETIC MOBILITY; FREEZE DRYING; GEL PERMEATION CHROMATOGRAPHY; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; LIGHT SCATTERING; MACROPHAGE; MALE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANIMALS; DIFFUSION; IMMUNIZATION; INTESTINES; LIPOSOMES; MANNANS; MOUTH MUCOSA; NANOCAPSULES; RATS; SERUM ALBUMIN, BOVINE; VACCINES;

EID: 84898442761     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1800     Document Type: Article

References (42)

1. E. L. Giudice and J. D. Campbell, Needle-free vaccine delivery. Adv. Drug Del. Rev. 58, 68 (2006).
2. A. des Rieux, V. Fievez, M. Garinot, Y.-J. Schneider, and V. Préat, Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J. Control. Release 116, 1 (2006).
3. H. Rothkötter, R. Pabst, and M. Bailey, Lymphocyte migration in the intestinal mucosa: Entry, transit and emigration of lymphoid cells and the influence of antigen. Vet. Immunol. Immunopathol. 15, 157 (1999).
4. K. Y. Pang, W. A. Walker, and K. J. Bloch, Intestinal uptake of macromolecules. Differences in distribution and degradation of protein antigen in control and immunised rats. Gut 22, 1018 (1981).
5. I. Van der Lubben, C. Verhoef, A. van Aelst, G. Borchard, and H. Juninger, Chitosan microparticles for oral vaccination: Preparation, characterisation and preliiminary in vivo uptake studies in murine Peyer's patches. Biomaterials 22, 687 (2001).
6. S. Jain, S. Kumar, A. K. Agrawal, K. Thanki, and U. C. Banerjee, Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes. Mol. Pharmaceutics 10, 2416 (2013).
7. J. Myschik, T. Rades, and S. Hook, Advances in lipid-based subunit vaccine formulations. Curr. Immunol. Rev. 5, 42 (2009).
8. O. Borges, G. Borchard, J. Verhoef, A. Sousa, and H. Junginger, Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int. J. Pharm. 299, 155 (2005).
9. J. Mann, H. Scales, E. Shakir, J. Alexander C. Katharine A. Mullen, and V. Ferro, Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity. Methods 38, 90 (2006).
10. E. Lilia Romero and M. J. Morilla, Topical and mucosal liposomes for vaccine delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3, 356 (2011).
11. A. K. Agrawal, M. Das, and S. Jain, In situ gel systems as' smart'carriers for sustained ocular drug delivery. Expert Opin. Drug Deliv. 9, 383 (2012).
12. M. Conacher, J. Alexander, and J. Brewer, Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine 19, 2965 (2001).
13. A. Frey, K. Giannasca, R. Weltzin, P. Giannasca, H. Regggio, I. Lencer, and M. Neutra, Role of glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184, 1045 (1996).
14. P. Jani, G. W. Halbert, J. Langridge, and A. T. Florence, The ptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41, 809 (1989).
15. S. Jain, P. Singh, V. Mishra, and S. P. Vyas, Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol. Lett. 101, 41 (2005).
16. P. Singh, D. Prabakaran, S. Jain, V. Mishra, K. S. Jaganathan, and S. P. Vyas, Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. Int. J. Pharm. 278, 379 (2004).
17. F. Ahsana, I. Rivasb, M. Khana, and A. T. Suarez, Targeting to macrophages: Role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J. Control. Release 79, 29 (2002).
18. S. Jain and S. P. Vyas, Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J. Liposome Res. 16, 331 (2006).
19. M. Sugimoto, K. Ohishi, M. Fukasawa, K. Shikata, H. Kawai, H. Itakura, M. Hatanaka, R. Sakakibara, M. Ishiguro, M. Nakata, and T. Mizuochi, Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity. FEBS Lett. 363, 53 (1995).
20. Y. Shimizu, H. Takagi, T. Nakayama, K. Yamakami, T. Tadakuma, N. Yokoyama, and N. Kojima, Intraperitoneal immunization with oligomannose-coated liposome-entrapped soluble leishmanial antigen induces antigen-specific T-helper type immune response in BALB/c mice through uptake by peritoneal macrophages. Parasite Immunol. 29, 229 (2007).
21. K. Wang and Z. He, Alginate-konjac glucomannan-chitosan beads as controlled release matrix. Int. J. Pharm. 244, 117 (2002).
22. J. Du, R. Sun, S. Zhang, L. F. Zhang, C. D. Xiong, and Y. X. Peng, Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. I. Physicochemical characterization of the carboxymethyl konjac glucomannan-chitosan nanoparticles. Biopolymers 78, 1 (2005).
23. M. Cuna, M. Alonso-Sandel, C. Remunan-Lopez, J. P. Pivel, J. L. Alonso-Lebrero, and M. J. Alonso, Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. J. Nanosci. Nanotechnol. 6, 2887 (2006).
24. M. Alonso-Sande, M. Cuna, C. Remunan-Lopez, D. Teijeiro-Osorio, J. L. Alonso-Lebrero, and M. J. Alonso, Formation of new glucomannan-chitosan nanoparticles and study of their ability to associate and deliver proteins. Macromolecules 39, 4152 (2006).
25. N. T. An, N. T. Dong, P. L. Dung, and D. T. Thien, Synthesis and characterization of water-soluble O-carboxymethyl glucomannan derivatives. Carbohydr. Polym. 83, 645 (2011).
26. S. Jain, J. M. Sharma, A. K. Agrawal, and R. R. Mahajan, Surface stabilized efavirenz nanoparticles for oral bioavailability enhancement. J. Biomed. Nanotechnol. 9, 1862 (2013).
27. S. Jain, V. V. Rathi, A. K. Jain, M. Das, and C. Godugu, Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine 7, 1311 (2012).
28. S. Jain, S. R. Patil, N. K. Swarnakar, and A. K. Agrawal, Oral delivery of doxorubicin using novel polyelectrolytes stabilized liposomes (Layersomes). Mol. Pharmaceutics 9, 2626 (2012).
29. H. Choudhary, A. Agrawal, R. Malviya, S. Yadav, Y. Jaliwala, and U. Patil, Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa. Pharmazie 65, 194 (2010).
30. B. Sarmento, A. Ribeiro, F. Veiga, P. Sampaio, R. Neufeld, and D. Ferreira, Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res. 24, 2198 (2007).
31. A. Agrawal, P. Gupta, A. Khanna, R. Sharma, H. Chandrabanshi, N. Gupta, U. Patil, and S. Yadav, Development and characterization of in situ gel system for nasal insulin delivery. Pharmazie 65, 188 (2010).
32. S. McClean, E. Prosser, E. Meehan, D. O'Malley, N. Clarke, Z. Ramtoola, and D. Brayden, Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6, 153 (1998).
33. F. Sarti, G. Perera, F. Hintzen, K. Kotti, V. Karageorgiou, O. Kammona, C. Kiparissides, and A. Bernkop-Schnürch, In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A. Biomaterials 32, 4052 (2011).
34. A. Vila, A. Sanchez, K. Janes, I. Behrens, T. Kissel, J. L. V. Jato, and M. J. Alonso, Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur. J. Pharm. Biopharm. 57, 123 (2004).
35. Y. Zhu, X. Li, C. Chen, F. Wang, J. Li, C. Hu, Y. Li, and L. Miao, Effects of aluminum trichloride on the trace elements and cytokines in the spleen of rats. Food Chem. Toxicol. 50, 2911 (2012).
36. T. J. McIntosh and S. A. Simon, Roles of bilayer material properties in function and distribution of membrane proteins. Annu. Rev. Biophys. Biomol. Struct. 35, 177 (2006).
37. E. K. Wasan, D. L. Reimer, and M. B. Bally, Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. J. Pharm. Sci. 85, 427 (1996).
38. S. Jain, D. Kumar, N. K. Swarnakar, and K. Thanki, Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. Biomaterials 33, 6758 (2011).
39. K. Furumoto, S. Nagayama, K.-I. Ogawara, Y. Takakura, M. Hashida, K. Higaki, and T. Kimura, Hepatic uptake of negatively charged particles in rats: possible involvement of serum proteins in recognition by scavenger receptor. J. Control. Release 97, 133 (2004).
40. P. J. Tacken and C. G. Figdor, Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines. Semin. Immunol. 23, 12 (2011).
41. I. R. Mackay, F. S. Rosen, and G. Ada, Vaccines and vaccination. New. Engl. J. Med. 345, 1042 (2001).
42. F. Belardelli, Role of interferons and other cytokines in the regulation of the immune response. APMIS 103, 161 (1995).